Rethinking the Timeline Required for Quality by Design Studies in Protein Process Development
Learn more about improving systems for rapid small-scale protein purification and analysis in order to obtain sample numbers for statistically significant analyses required for the selection of lead candidate molecules as an ongoing challenge.
In this video we’ll explore how Quality by Design (QbD) timelines can be accelerated through the high-throughput miniaturization of purification workflows and subsequent characterization of relevant proteins.
| Presented By | |
 |
Louis Fabri Director of Protein Technologies, CSL |
 |
Bill Flaherty Biopreocess Scientist, Merrimack Pharmaceuticals |
Watch our video and learn more
